Literature DB >> 10841242

Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group.

H Calkins1, A Epstein, D Packer, A M Arria, J Hummel, D M Gilligan, J Trusso, M Carlson, R Luceri, H Kopelman, D Wilber, J M Wharton, W Stevenson.   

Abstract

OBJECTIVES: The purpose of this multicenter study was to evaluate the safety and efficacy of a radiofrequency (RF) catheter ablation system with internal saline irrigation.
BACKGROUND: Catheter ablation of ventricular tachycardia (VT) associated with structural heart disease is more difficult than ablation of idiopathic VT. The larger size of responsible reentrant circuits contributes to the difficulty in achieving an adequate ablation lesion with conventional techniques. Recently, cooling of the ablation electrode by saline irrigation has been shown to increase RF lesion size.
METHODS: The patient population included 146 patients who participated in the Cooled RF Ablation System clinical trial and underwent an attempt at ablation of VT occurring in the presence of structural heart disease. The duration of follow-up was 243 +/- 153 days.
RESULTS: Catheter ablation was acutely successful, as defined by elimination of all mappable VTs, in 106 patients (75%). In 59 patients (41%), no VT of any type was inducible after ablation. Twelve patients (8%) experienced a major complication. After catheter ablation, 66 patients (46%) developed one or more episodes of a sustained ventricular arrhythmia.
CONCLUSIONS: The results of this study demonstrate that catheter ablation of all mappable forms of sustained VT can be performed with high initial success and a moderate incidence of major complications (8%).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841242     DOI: 10.1016/s0735-1097(00)00615-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  78 in total

Review 1.  Radiofrequency catheter ablation of ventricular tachycardia.

Authors:  W G Stevenson; E Delacretaz
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators?

Authors:  K K Talwar; N Naik; R Juneja
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 3.  [Catheter ablation of ventricular arrhythmias. Complications and emergency situations].

Authors:  Kristina Wasmer; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-12

Review 4.  Alzheimer's disease: the impact of age-related changes in reproductive hormones.

Authors:  C S Atwood
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  Deciphering cryptic proteases.

Authors:  M A Liz; M M Sousa
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

6.  What is the most appropriate energy source for aortic cusp ablation? A comparison of standard RF, cooled-tip RF and cryothermal ablation.

Authors:  Andre d'Avila; Aravinda Thiagalingam; Godtfred Holmvang; Christopher Houghtaling; Jeremy N Ruskin; Vivek Y Reddy
Journal:  J Interv Card Electrophysiol       Date:  2006-10-07       Impact factor: 1.900

7.  Ablation of ventricular tachycardia.

Authors:  F C Garcia; E Valles; S Dhruvakumar; F E Marchlinski
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

8.  [Guidelines for catheter ablation].

Authors:  Karl-Heinz Kuck; Sabine Ernst; Uwe Dorwarth; Ellen Hoffmann; Heinz Pitschner; Jürgen Tebbenjohanns; Hans Kottkamp
Journal:  Clin Res Cardiol       Date:  2007-11       Impact factor: 5.460

9.  Gene therapy approaches to ventricular tachyarrhythmias.

Authors:  J Kevin Donahue; Tetsuo Sasano; Kamilla Kelemen
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

Review 10.  Radiofrequency ablation of cancer.

Authors:  Marc Friedman; Igor Mikityansky; Anthony Kam; Steven K Libutti; McClellan M Walther; Ziv Neeman; Julia K Locklin; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-03       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.